Jia-Zhou Ye
Overview
Explore the profile of Jia-Zhou Ye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
638
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mai R, Ye J, Gao X, Wen T, Li S, Zeng C, et al.
Eur J Pharmacol
. 2024 Nov;
986:177102.
PMID: 39603378
The pre-metastatic niche constructed by cancer-associated fibroblasts (CAFs) plays a key role in the hypoxic tumor microenvironment (TME), promoting hepatocellular carcinoma (HCC) metastasis. Integrin, which is involved in cell-to-cell or...
2.
Bai T, Mai R, Tang Z, Wang X, Chen J, Ye J, et al.
Viral Immunol
. 2024 Nov;
37(9):432-439.
PMID: 39601371
This study aims to explore the mechanism underlying the role of ubiquitin-specific protease 14 (USP14) in regulating P53 expression and influencing the development of hepatitis B. The animal and cell...
3.
Ye J, Lu H, Zeng C, Lei G, Wang X, Chen J, et al.
BMC Cancer
. 2024 Jun;
24(1):764.
PMID: 38918786
Objective: Clinically significant portal hypertension (CSPH) seriously affects the feasibility and safety of surgical treatment for hepatocellular carcinoma (HCC) patients. The aim of this study was to establish a new...
4.
Bai T, Tang Z, Wang X, Chen J, Ye J, Lu S, et al.
Langenbecks Arch Surg
. 2024 Mar;
409(1):97.
PMID: 38488934
Background: This study was recruited to compare the efficacy and safety of radiotherapy (RT) and transarterial chemoembolization (TACE) as postoperative adjuvant therapy after narrow-margin hepatectomy in hepatocellular carcinoma (HCC) patients....
5.
Mai R, Lu T, Lu R, Zeng C, Lian F, Li L, et al.
J Inflamm Res
. 2024 Feb;
17:919-931.
PMID: 38370468
Background: Systemic inflammatory response is a hallmark of cancer and plays a significant role in the development and progression of various malignant tumors. This research aimed to estimate the prognostic...
6.
Yang S, Feng J, Yan M, Guo L, Duan Y, Ye J, et al.
Hepatol Int
. 2023 Apr;
17(5):1251-1264.
PMID: 37060489
Purpose: This study aimed at analyzing and comparing the perioperative results and long-term oncological outcomes of hepatocellular carcinoma (HCC) patients with type 2 diabetes mellitus (T2DM) treated with laparoscopic (LLR)...
7.
Yang S, Yan M, Feng J, Duan Y, Ye J, Liu Z, et al.
Front Oncol
. 2023 Jan;
12:979434.
PMID: 36591472
Background: The effect of type 2 diabetes mellitus (T2DM) on survival of patients with hepatocellular carcinoma (HCC) after laparoscopic liver resection (LLR) has not been reported. This study aimed to...
8.
Yang S, Yan M, Duan Y, Feng J, Ye J, Xiang Y, et al.
Hepatol Int
. 2022 Jun;
16(4):892-905.
PMID: 35704267
Purpose: To analyze the long-term oncological outcomes of Barcelona Clinic Liver Cancer (BCLC) stages 0-A hepatocellular carcinoma (HCC) patients associated with or without microvascular invasion (MVI) treated with laparoscopic versus...
9.
Lu H, Mai R, Wang X, Chen J, Bai T, Ma L, et al.
Future Oncol
. 2022 Jun;
18(21):2683-2694.
PMID: 35699041
Finding a way to comprehensively integrate the presence and grade of clinically significant portal hypertension, amount of preserved liver function and extent of hepatectomy into the guidelines for choosing appropriate...
10.
Su T, Li L, Liang S, Xiang B, Li J, Ye J, et al.
Front Oncol
. 2021 Sep;
11:680303.
PMID: 34513671
Background: In this study, we designed a new (Su'S) target area delineation to protect the normal liver during liver regeneration and prospectively evaluate liver regeneration after radiotherapy, as well as...